1. Home
  2. SCLX vs MLEC Comparison

SCLX vs MLEC Comparison

Compare SCLX & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • MLEC
  • Stock Information
  • Founded
  • SCLX 2011
  • MLEC 2008
  • Country
  • SCLX United States
  • MLEC United Kingdom
  • Employees
  • SCLX N/A
  • MLEC N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • MLEC Blank Checks
  • Sector
  • SCLX Health Care
  • MLEC Finance
  • Exchange
  • SCLX Nasdaq
  • MLEC Nasdaq
  • Market Cap
  • SCLX 33.9M
  • MLEC 36.0M
  • IPO Year
  • SCLX N/A
  • MLEC N/A
  • Fundamental
  • Price
  • SCLX $6.30
  • MLEC $5.76
  • Analyst Decision
  • SCLX Strong Buy
  • MLEC
  • Analyst Count
  • SCLX 3
  • MLEC 0
  • Target Price
  • SCLX $367.50
  • MLEC N/A
  • AVG Volume (30 Days)
  • SCLX 100.7K
  • MLEC 15.4K
  • Earning Date
  • SCLX 08-12-2025
  • MLEC 07-15-2025
  • Dividend Yield
  • SCLX N/A
  • MLEC N/A
  • EPS Growth
  • SCLX N/A
  • MLEC N/A
  • EPS
  • SCLX N/A
  • MLEC N/A
  • Revenue
  • SCLX $50,710,000.00
  • MLEC N/A
  • Revenue This Year
  • SCLX $107.00
  • MLEC $20.42
  • Revenue Next Year
  • SCLX $82.52
  • MLEC $30.00
  • P/E Ratio
  • SCLX N/A
  • MLEC N/A
  • Revenue Growth
  • SCLX 7.79
  • MLEC 170.36
  • 52 Week Low
  • SCLX $3.60
  • MLEC $5.30
  • 52 Week High
  • SCLX $73.50
  • MLEC $10.90
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 60.64
  • MLEC 37.63
  • Support Level
  • SCLX $6.00
  • MLEC $5.78
  • Resistance Level
  • SCLX $6.76
  • MLEC $6.68
  • Average True Range (ATR)
  • SCLX 0.42
  • MLEC 0.85
  • MACD
  • SCLX 0.11
  • MLEC -0.10
  • Stochastic Oscillator
  • SCLX 82.06
  • MLEC 14.77

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Share on Social Networks: